CBN and sleep: a practical guide to an evening ritual

This double-blind, placebo-controlled trial remains the most solid data available on CBN. Over seven nights, the 310 participants received either a placebo, or 20 mg of CBN alone, or 20 mg of CBN combined with various doses of CBD. The result is nuanced: overall sleep quality, the primary endpoint, did not reach the threshold of statistical significance. The CBN-alone group, on the other hand, showed a significant reduction in night-time awakenings (p = 0.025) compared with placebo, and adding CBD did not improve that result. This is a single short trial, partly industry-funded, which needs to be replicated before any definitive conclusion. For details of the regulatory status of CBN, see our article on its legal framework in France.

Prescription sleeping pills (zolpidem, zopiclone, hypnotic benzodiazepines) act on the GABA receptors of the central nervous system. They shorten the time it takes to fall asleep but carry a risk of tolerance and dependence; the HAS limits their prescription to 28 days. Melatonin, a natural hormone secreted by the pineal gland, resynchronises the sleep-wake rhythm at low doses (0.5 to 2 mg); above that, it is classed as a medicine in France. CBN acts on neither of these two mechanisms: current hypotheses describe it as interacting with the endocannabinoid system, without sufficient clinical validation to date to make it an official recommendation.

Four practical pointers for anyone wanting to try a CBN product:

1. Quantity: the only clinical data available concerns 20 mg in a single dose. Starting lower (10 to 15 mg) makes it possible to gauge your individual tolerance.
2. Timing: 30 to 60 minutes before bed, at a fixed time. Regular bedtimes often matter more than the dose itself.
3. Product quality: insist on a certificate of analysis (CoA) stating the exact CBN content, the absence of banned cannabinoids (HHC, H4CBD, THCP) and THC below 0.30%.
4. Driving: a full-spectrum or broad-spectrum product may contain traces of THC detectable by a saliva test. If you are driving the next morning, favour a CBN isolate certified THC-free.

The reference strategy of the HAS remains: optimising sleep hygiene as the first-line approach, then cognitive behavioural therapy for insomnia (CBT-I) if that fails, then medication as a last resort and for the shortest possible time. CBN appears in none of these steps; at best it can fit in as a complement, never as a substitute.

No CBN product has marketing authorisation as a medicine in France: any claim that it "treats insomnia" would expose the brand to reclassification as a medicine by presentation. CBN is not recommended for pregnant or breastfeeding women, for minors, or for people on medication metabolised by the CYP3A4 and CYP2C9 enzymes. If your sleep problems persist beyond three weeks, or are accompanied by marked daytime sleepiness, consult a healthcare professional: chronic insomnia calls for medical care.

How long before an effect is felt?

The available clinical trial covered seven consecutive nights. No data documents an effect from the first dose; users who report a benefit generally speak of several nights of regular use.

Can CBN and melatonin be combined?

No study has assessed the safety of this combination. As a precaution, avoid stacking several sleep aids without medical advice, especially if melatonin has been prescribed to you.

Is CBN alone more effective than CBN + CBD?

According to the Bonn-Miller 2024 trial, CBN alone showed a reduction in night-time awakenings that adding CBD did not improve. A single study is not enough, however, to establish a general rule.

Does CBN cause a positive saliva test?

A full-spectrum or broad-spectrum CBN product contains residual traces of THC that may trigger a positive roadside test. Favour an isolate certified THC-free if you have to drive.